Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
AMILI logo — AMILI is a precision gut microbiome company based in Singapo...

AMILI

AMILI is a precision gut microbiome company based in Singapore serving the region.

Founded 2019 Singapore Singapore 40 employees Series Unknown Total: $10.50M Health Care, Health and Wellness +1

General Information

Company Name AMILI
Founded Year 2019
Location Singapore Singapore +1
Employees 40
Industries Health Care, Health and Wellness, Sports
Funding Stage Series Unknown
Social

Get notified when AMILI moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AMILI

AMILI is a precision gut microbiome company based in Singapore, serving the region. Through AMILI's proprietary analytics engine, PRIME, they develop diagnostics tests, predictive algorithms, and microbiome-modifying interventions. Their consumer health arm, BIO & ME, utilizes insights from AMILI's database and PRIME to generate Asia-centric solutions towards personalized diet, supplementation, and precision health. AMILI also houses Southeast Asia's first and only gut microbiome bank for clinical use and research. The company, founded in 2019, operates in the Health Care industry. Their most recent Venture Round investment occurred on 29 May 2023, with investment from East Ventures. For more information, visit www.amili.asia.

Taxonomy: Precision Gut Microbiome, Diagnostics Tests, Predictive Algorithms, Microbiome-Modifying Interventions, Consumer Health, Personalised Diet, Supplementation, Precision Health, Microbiome Database, Faecal Microbiota Transplants, Stool Bank, Research and Development, Innovation, Probiotics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Unknown 1
East Ventures
29 May 2023
Series A $10.50M 9
SEEDS Capital TVM Capital Healthcare Blue7 Capital Code PRUKSA
Pureland Venture, Grab +2 		15 Jun 2022

AMILI Alternatives & Competitors

AMILI vs
DayTwo
DayTwo United States

Precision Nutrition for Metabolic Disease

Unknown
16 employees
Biotechnology, Health Care
Compare AMILI vs DayTwo
AMILI vs
Xbiome
Xbiome United States

China's leading AI-driven microbiome drug development company

Series B
51 employees
AI, Biotechnology
Compare AMILI vs Xbiome
AMILI vs
OSbiome
OSbiome Singapore

💩 Understand what your gut truly needs and experience your true health.

Seed
2 employees
Health Care, Health and Wellness
Compare AMILI vs OSbiome

FAQ About AMILI

AMILI is a precision gut microbiome company based in Singapore serving the region.
AMILI was founded in 2019.
AMILI is headquartered in Singapore.
AMILI operates in the following industries: Health Care, Health and Wellness, Sports.
AMILI has approximately 40 employees.
AMILI has completed 2 funding rounds, raising a total of $10.50M. The latest funding stage is Series Unknown.
Top alternatives and competitors to AMILI include DayTwo, Xbiome, OSbiome, Evolve Biosystems, MD NutriAcademy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AMILI and DayTwo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AMILI and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy